Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Thrombotic+thrombocytopenic+purpura%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
/vufind/Search/Results?lookfor=%22Thrombotic+thrombocytopenic+purpura%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
Search /vufind/Search2/Results?lookfor=%22Thrombotic+thrombocytopenic+purpura%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
PubPharm (126)
1
Cablivi Injection 10mg Drug Use Investigation for patients with aTTP : Cablivi Injection 10mg Drug Use Investigation for patients with aTTP - Cablivi Injection 10mg Drug Use Investigation for patients with aTTP
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Cablivi Injection 10mg Drug Use Investigation for patients with aTTP : Cablivi Injection 10mg Drug Use Investigation for patients with aTTP - Cablivi Injection 10mg Drug Use Investigation for patients with aTTP
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A Phase 3b, prospective, open-label, multicenter, single treatment arm, continuation study of the safety and efficacy of TAK-755 (rADAMTS-13, also known as BAX 930/SHP655) in the prophylactic and on-demand treatment of subjects with severe congenital thrombotic thrombocytopenic purpura (cTTP; Upshaw-Schulman Syndrome, or hereditary thrombotic thrombocytopenic purpura) : A Phase 3b, prospective, open-label, multicenter, single treatment arm, continuation study of the safety and efficacy of TAK-755 (rADAMTS-13, also known as BAX 930/SHP655) in the prophylactic and on-demand treatment of subjects with severe congenital thrombotic thrombocytopenic purpura (cTTP; Upshaw-Schulman Syndrome, or hereditary thrombotic thrombocytopenic purpura)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A Phase 3b, prospective, open-label, multicenter, single treatment arm, continuation study of the safety and efficacy of TAK-755 (rADAMTS-13, also known as BAX 930/SHP655) in the prophylactic and on-demand treatment of subjects with severe congenital thrombotic thrombocytopenic purpura (cTTP; Upshaw-Schulman Syndrome, or hereditary thrombotic thrombocytopenic purpura) : A Phase 3b, prospective, open-label, multicenter, single treatment arm, continuation study of the safety and efficacy of TAK-755 (rADAMTS-13, also known as BAX 930/SHP655) in the prophylactic and on-demand treatment of subjects with severe congenital thrombotic thrombocytopenic purpura (cTTP; Upshaw-Schulman Syndrome, or hereditary thrombotic thrombocytopenic purpura)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A Phase 2b study of TAK-755 (rADAMTS13) with minimal to no PEX in the treatment of patients with iTTP : A Phase 2b, multicenter, randomized, double-blind study of safety and efficacy of TAK-755 (rADAMTS13) with minimal to no plasma exchange (PEX) in the treatment of immune-mediated thrombotic thrombocytopenic purpura (iTTP)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A Phase 2b study of TAK-755 (rADAMTS13) with minimal to no PEX in the treatment of patients with iTTP : A Phase 2b, multicenter, randomized, double-blind study of safety and efficacy of TAK-755 (rADAMTS13) with minimal to no plasma exchange (PEX) in the treatment of immune-mediated thrombotic thrombocytopenic purpura (iTTP)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A continuation study to evaluate the prophylactic and on demand treatment of congenital Thrombotic Thrombocytopenic Purpura (cTTP) with the drug TAK-755 (rADAMTS-13, also known as BAX 930/SHP655) : A Phase 3b, prospective, open-label, multicenter, single treatment arm, continuation study of the safety and efficacy of TAK-755 (rADAMTS-13, also known as BAX 930/SHP655) in the prophylactic and on-demand treatment of subjects with severe congenital thrombotic thrombocytopenic purpura (cTTP; Upshaw Schulman Syndrome, or hereditary thrombotic thrombocytopenic purpura)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Caplacizumab and immunosuppressive therapy without first line therapeutic plasma exchange in adults with immune-mediated thrombotic thrombocytopenic purpura : An open-label, single-arm, multicenter study to evaluate the efficacy and safety of caplacizumab and immunosuppressive therapy without first line therapeutic plasma exchange in adults with immune-mediated thrombotic thrombocytopenic purpura
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A continuation study to evaluate the prophylactic and on demand treatment of congenital Thrombotic Thrombocytopenic Purpura (cTTP) with the drug TAK-755 (rADAMTS-13, also known as BAX 930/SHP655) : A Phase 3b, prospective, open-label, multicenter, single treatment arm, continuation study of the safety and efficacy of TAK-755 (rADAMTS-13, also known as BAX 930/SHP655) in the prophylactic and on-demand treatment of subjects with severe congenital thrombotic thrombocytopenic purpura (cTTP; Upshaw Schulman Syndrome, or hereditary thrombotic thrombocytopenic purpura)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Caplacizumab and immunosuppressive therapy without first line therapeutic plasma exchange in adults with immune-mediated thrombotic thrombocytopenic purpura : An open-label, single-arm, multicenter study to evaluate the efficacy and safety of caplacizumab and immunosuppressive therapy without first line therapeutic plasma exchange in adults with immune-mediated thrombotic thrombocytopenic purpura
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
126
Aufsätze
126
E-Artikel
126
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
126
610
120
Study Type: Interventional
70
Recruitment Status: Not yet recruiting
66
Phase: Phase 3
30
Recruitment Status: Authorised-recruitment may ...
24
Phase: Phase 2
12
Medical Condition: Acquired thrombotic thromboc...
10
Medical Condition: congenital Thrombotic thromb...
10
Medical Condition: severe congenital thrombotic...
8
Medical Condition: Acquired Thrombotic thromboc...
6
Medical Condition: Acquired Thrombotic thromboc...
6
Medical Condition: Acquired thrombotic thromboc...
6
Medical Condition: acquired thrombotic thromboc...
6
Phase: Phase 1
6
Recruitment Status: Recruiting
6
Study Type: Observational
4
Medical Condition: Acquired Thrombotic thromboc...
4
Medical Condition: Subjects diagnosed with here...
4
Medical Condition: Thrombotic Thrombocytopenic ...
4
Recruitment Status: Completed
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
66
2020-
60
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
124
Englisch
2
Unbestimmt
Haven't found what you're looking for?
Wird geladen...